TY - JOUR
AU - Anderson, Michael
AU - Pitchforth, Emma
AU - Asaria, Miqdad
AU - Brayne, Carol
AU - Casadei, Barbara
AU - Charlesworth, Anita
AU - Coulter, Angela
AU - Franklin, Bryony Dean
AU - Donaldson, Cam
AU - Drummond, Michael
AU - Dunnell, Karen
AU - Foster, Margaret
AU - Hussey, Ruth
AU - Johnson, Paul
AU - Johnston-Webber, Charlotte
AU - Knapp, Martin
AU - Lavery, Gavin
AU - Longley, Marcus
AU - Clark, Jill Macleod
AU - Majeed, Azeem
AU - McKee, Martin
AU - Newton, John N.
AU - O'Neill, Ciaran
AU - Raine, Rosalind
AU - Richards, Mike
AU - Sheikh, Aziz
AU - Smith, Peter
AU - Street, Andrew
AU - Taylor, David
AU - Watt, Richard G
AU - Whyte, Moira
AU - Woods, Michael
AU - McGuire, Alistair
AU - Mossialos, Elias
PY - 2021
DA - May
TI - LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19
JO - The Lancet
EP - 1978
VL - 397
IS - 10288
DO - https://doi.org/10.1016/S0140-6736(21)00232-4
AB - The UK has recorded one of the highest death rates associated with COVID-19 globally, whether measured as deaths that are directly attributable to COVID-19 or by excess mortality. The reasons for this high rate are complex and not yet fully understood, but elements of the UK Government response have been criticised, including delayed implementation of physical distancing measures, poor coordination with local authorities and public health teams, a dysfunctional track and trace system, and an absence of consultation with devolved nations. The role of the National Health Service (NHS) and relevant national executive agencies in relation to testing capacity, availability of personal protective equipment (PPE), the cancellation and postponement of many aspects of routine care, and decisions around discharge from hospital to care homes should also be critically examined. Conversely, aspects of the response by the NHS and relevant national executive agencies deserve recognition. In only a few weeks, capacity for critical care was massively expanded, many thousands of staff were reallocated, and services were reorganised to reduce transmission of SARS-CoV-2. The NHS also collaborated with academic institutions to share knowledge about clinical characteristics of the disease and to establish world-leading clinical trials on vaccines and treatments.
PB - Elsevier
UR - https://www.research.ed.ac.uk/portal/en/publications/lselancet-commission-on-the-future-of-the-nhs(1e7d116a-1a35-40eb-a27f-177727a4372f).html
KW - Coronavirus (COVID-19)
KW - Service recovery and remobilisation
ER